SuperworthAkari Therapeutics Plc market cap AKTX
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $640.6M
- Highest close in our data
- $893.3M
- Sep 2026
Akari Therapeutics Plc is worth $640.6M at the close on Oct 23, 2026, at $8.23 a share.
That is up 2554% over the last year and up 19959% over five years.
Its highest close in our data was $893.3M in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $640.6M | $3.1M | $893.3M | +6644% |
| 2025 | $9.5M | $9.3M | $43.4M | −60% |
| 2024 | $24M | $336.9K | $45.9M | +4028% |
| 2023 | $580.7K | $430.8K | $1.3M | −48% |
| 2022 | $1.1M | $1.1M | $3.5M | −61% |
| 2021 | $2.9M | $2.3M | $4.5M | +39% |
| 2020 | $2.1M | $956.3K | $2.8M | +53% |
| 2019 | $1.4M | $1.3M | $3.1M | +9% |
| 2018 | $1.2M | $1.1M | $2.4M | −51% |
| 2017 | $2.5M | $2M | $12.1M | −38% |
| 2016 | $4.1M | $4.1M | $11.1M | −51% |
| 2015 | $8.5M | $12.2K | $11.4M | +41847% |
| 2014 | $20.4K | $1.7K | $27.4K | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Akari Therapeutics Plc's size, closest first, today.
| Company | Market cap |
|---|---|
| AKTXAkari Therapeutics Plc | $640.6M |
| CRMDCorMedix | $611.9M |
| ZVRAZevra Therapeutics | $582.6M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PBYIPuma Biotechnology | $568.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| ARVNArvinas | $477.3M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| PCRXPacira BioSciences | $1.5B |
| Peer median | $679.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Akari Therapeutics Plc
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.